Back
AudioEye, Inc. 10K Form
Sell
42
AEYE
AudioEye, Inc.
Last Price:
$12.94
Seasonality Move:
30.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-13 | 10Q | AEYE/AudioEye, Inc. Quarterly |
| 2021-03-11 | 10K | AEYE/AudioEye, Inc. Annual |
| 2020-11-13 | 10Q | AEYE/AudioEye, Inc. Quarterly |
| 2020-08-13 | 10Q | AEYE/AudioEye, Inc. Quarterly |
| 2020-05-15 | 10Q | AEYE/AudioEye, Inc. Quarterly |
| 2020-03-30 | 10K | AEYE/AudioEye, Inc. Annual |
Receive AEYE News And Ratings
See the #1 stock for the next 7 days that we like better than AEYE
AEYE Financial Statistics
Sales & Book Value
| Annual Sales: | $35.2M |
|---|---|
| Cash Flow: | $559K |
| Price / Cash Flow: | 194.07 |
| Annual Sales: | $0.46 |
| Price / Book: | 28.61 |
Profitability
| EPS (TTM): | -0.28560 |
|---|---|
| Net Income (TTM): | $-3.5M |
| Gross Margin: | $27.9M |
| Return on Equity: | -46.55% |
| Return on Assets: | -11.15% |
AudioEye, Inc. Earnings Forecast
Key AudioEye, Inc. Financial Ratios
-
The Gross Profit Margin over the past 15 years for AEYE is 79.37%.
-
The Selling, General & Administrative Expenses for AEYE have been equal to 74.58% of Gross Profit Margin.
-
The Research & Development expenses have been 14.42% of Revenue.
-
The Net Earning history of AEYE is -12.08% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 8 years.
AudioEye, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | AEYE |
| CUSIP: | 050734 |
| Website: | audioeye.com |
Debt
| Debt-to-Equity Ratio: | 2.34 |
|---|---|
| Current Ratio: | 1 |
| Quick Ratio: | 0.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 15.28 |
AEYE Technical Analysis vs Fundamental Analysis
Sell
42
AudioEye, Inc. (AEYE)
is a Sell
Is AudioEye, Inc. a Buy or a Sell?
-
AudioEye, Inc. stock is rated a SellThe current AudioEye, Inc. [AEYE] share price is $13.02. The Score for AEYE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.